FDA Approves Levaquin Short-Course Therapy Treatment Industry, health groups’ alarm grows as tamper-proof deadline approaches Congress will not legislate generic biotech medications Chephalon finalizes label revisions for Provigil Eli Lilly settles with whistleblower for $100,000 New York joins state lawsuits over Vioxx FDA approves new dosage of MedPointe's Soma article-11489.xml World of Hair introduces two new products Unilever and PepsiCo to expand ready-to-drink tea joint venture First Previous 6566 6567 6568 6569 6570 Next Last